SQC News Issue 3
2020-11-02 16:00
Direct Investment
AI Business Services Company ImageDT has completed Series B Financing of Multimillion Dollar
FoF Investment
Starquest Capital's portfolio GPs made investments in Healthcare, Consumption and Technology
From July to October 2020, Starquest Capital's portfolio GPs completed investments in healthcare, consumption and technology.
Healthcare
Highlight Capital (HLC) led the investment in series D+ round of financing of a pharmaceutical CRO and CDMO enterprise Bellen Chemistry, and completed a new round of financing rapidly after obtaining several hundred million yuan of D round of financing in June.
HLC also led the investment with CPE and Yingke PE in Hanyu Medical, a heart valve interventional medical devices provider. Other investors of Hanyu Medical include Everest VC, Med-Fine Capital, TAF Capital.
Sherpa Capital participated in nearly 100 million yuan of series A round of financing of Ikont, an ophthalmological medical device manufacturer. Other investors include Sequoia China, Fosun Capital, Green Pine Capital Partners, YuanBio VC and Hengqin Financial Investment.
Source Code Capital led a 60 million yuan of A3 round of financing in Hangzhou Joinhealth Technology, an AI disease management platform, and Sherpa Capital also participated in this round. Gaorong Capital and Sherpa Capital participated in the first round of financing of nearly 100 million yuan in Xsoft Technology, a hospital operation management system.
Consumption
Technology
Leto Laboratories, a protein new drug R&D firm,
Supremind, a video abnormal analysis AI data platform,
Doctopia, an internet maternal and child healthcare management platform,
Kyee, a smart medical program provider,
KK Group, a brand of new retail outlets,
AIPARK, a smart parking management system R&D firm,
WM Motor, a new-energy vehicle manufacturer,
Yaoyanshe, an innovative CRO platform,
Genecast, a tumor precision diagnosis service provider,
iSpace, a private carrier rockets.
Multiple deals are in process of IPOs
A number of Starquest portfolio companies are in process of IPOs. For example,
CHIVD, a chemiluminescence diagnostic technology developer,
XGIMI, a multi-functional smart projects and laser TVs manufacturer,
HOB Biotech Group, an innovative in vitro diagnostic firm which specialized in providing diagnostic tools for allergy and autoimmune diseases,
have been successfully approved by CSRC, and will proceed with IPO on STAR Market of Shanghai Stock Exchange. Li Auto Inc., made its debut in the US whose latest market capitalization reached about $16 billion.
Industry Recognition
Starquest Capital received multiple industry honors
In the last two months, Starquest Capital was awarded several industry honors by Zero2IPO Research, 36kr and CLPA, etc.
On August 12 and 13, Zero2IPO Research announced the China VC/PE Fund Limited Partners Ranking 2020 at the 14th China Fund Partners Summit, which was jointly hosted by TRJCN. Starquest Capital was named as the TOP 30 China VC/PE Institutional Limited Partners 2020.
On August 27, 36Kr released the 2020 China's TOP20 Fund of Funds Voted by General Partners and the 2020 China's TOP10 Fund of Funds in Direct Investment. Starquest Capital was on both lists.
On October 12, CLPA released the selection of China's Limited Partners in 2020, and Starquest Capital was named as the TOP5 Best Secondary Funds in 2019- 2020 and the TOP10 Best Market-oriented FOFs in 2019- 2020.
Mr. Frankie Fang, joined the Future Forum's List of Youth Council 2020, Promoting the Development of Science and Public Welfare Undertakings
The Future Forum, established in early 2015, is the only cross-fields nonprofit platform that supports science development in China. The Future Forum brought hundreds of global influential scientists, entrepreneurs and investors together, and in 2016, Future Science Prize was founded, aiming at recognizing scientific breakthroughs and innovations in Greater China region. Relying on the platform resources, Future Forum adheres to the mission of "Transform the Future with Science", and actively promotes the development of science and public welfare undertakings.
ESG Insight
In July 2020, Starquest Capital was invited to become a member of the nominating committee for the annual awards for the Green Responsible Investment Principles (GIP) for the Belt and Road Initiative.
In September, Starquest Capital was invited to attend the World Economic Forum's internal ESG symposium and delivered a keynote speech, in which Starquest Capital shared its ESG practices.
In October, the Practice of ESG Investment Management from the Perspective of Fund of Funds by Starquest Capital was selected in a case study on the Social Responsibility Report on Private Investment Funds (2020) issued by the Asset Management Association of China (AMAC). Since the release of the Report, it has attracted wide attention of the industry and the public. Starquest Capital performs its duties and actively practices responsible investment.
367次查看